Yuan M, Zhou L, Li W, Du X, Weng J, Yang L, Ma Y, Liu B, Liu Z, Wen Q, Zhao S, Zhang Y, Bai Q, Feng X, Han Y, Liu C, Meng L, Wang B, Ran X, Wang X, Zhang H, Zeng Y, Leng Q, Yu L, Li Z, Gale RP, Huang X, Jiang Q. Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation. haematol [Internet]. 2020Sep.10 [cited 2025Dec.7];. Available from: https://haematologica.org/article/view/12944